Mithrl

Biomedical world model for scientific decision-making in biopharma

mithrl.com

Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.

About

Mithrl builds a biomedical AI platform that grounds R&D decisions in validated biology. Its Mithrl-1 platform combines a proprietary biomedical world model with an agentic harness for model routing and orchestration, and is designed to deploy inside customer environments alongside proprietary data. The company says the platform helps teams identify targets and biomarkers, interpret results in biological context, and produce auditable insights. In September 2026 it announced a $20M Series A led by Obvious Ventures, with participation from Headline, AGI House, and pharma executives. Co-founders include CEO Vivek Adarsh and CTO Shara Balakrishnan.

Website
mithrl.com
Stage
series-a
Added via
web
Ownership
unclaimed

Where to go

Products

  • Mithrl-1 — Biomedical world model with agentic orchestration for R&D decisions

Social profiles

Founders